Cochrane Abstracts
Statins for Smith‐Lemli‐Opitz syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Statins for Smith‐Lemli‐Opitz Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432922/all/Statins_for_Smith‐Lemli‐Opitz_syndrome.
Statins for Smith‐Lemli‐Opitz syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432922/all/Statins_for_Smith‐Lemli‐Opitz_syndrome. Accessed November 26, 2024.
Statins for Smith‐Lemli‐Opitz syndrome. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432922/all/Statins_for_Smith‐Lemli‐Opitz_syndrome
Statins for Smith‐Lemli‐Opitz Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432922/all/Statins_for_Smith‐Lemli‐Opitz_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Statins for Smith‐Lemli‐Opitz syndrome
ID - 432922
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432922/all/Statins_for_Smith‐Lemli‐Opitz_syndrome
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
